SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

SaneVax: Why is a highly sensitive HPV test used in vaccine development and not for patient care?

By Leave a Comment

Sanevax square

By Norma Erickson, President The SaneVax Team wants to know why consultants paid by the pharmaceutical industry appear to be using the World Health Organization (WHO) and the National Cancer Institute (NCI) to promote a double standard of HPV testing to market “cervical cancer vaccines” at the expense of women’s health. Are HPV vaccine manufacturers, […]

[Continue reading...]

Human papillomavirus in the placenta and umbilical cord blood.

By Leave a Comment

PubMed.gov Acta Obstet Gynecol Scand. 2008;87(11):1181-8. Sarkola ME, Grénman SE, Rintala MA, Syrjänen KJ, Syrjänen SM. Source Department of Obstetrics and Gynecology, Turku University Central Hospital, Turku, Finland. marja.sarkola@utu.fi Abstract OBJECTIVE: To analyze human papillomavirus (HPV) DNA in umbilical cord blood and in placenta, including its cellular localization. DESIGN: Longitudinal prospective study. SETTING: Maternity Unit […]

[Continue reading...]

3 year gap in between Pap tests, apparently ok

By Leave a Comment

VIHC Vaccine Injury Help Center June 1, 2011 Most women aged 30 and older with normal Pap and human papillomavirus (HPV) test results can safely wait three years until their next set of cervical cancer screening tests, according to a new study discussed in an article written for WebMD Health News, published on May 18, […]

[Continue reading...]

News

Videos

Contact